| Leuprolide Acetate | Abbvie | ||
| 7.5 mg/Vial; Injection |
Less Than $1000 mn
|
||
| None | None | ||
|
More Than 5
|
None | ||
| None | None | ||
| Indicated for management of endometriosis, including pain relief and reduction of endometriotic lesions | |||
|
Yes
| |||
| Leuprolide Acetate | None | ||
| 22.5MG, 30MG, 45MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| LUPRON DEPOT is a gonadotropin releasing hormone (GnRH) agonist indicated for: • treatment of advanced prostatic cancer. | |||
|
Yes
| |||
| Lupron Depot | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||
| *********-******* *********** *** ****** *** ********* *** **** | *********-******* *********** *** ****** *** ********* *** **** | ********* ******* ************ *** *** ********** | ********* ******* ************* | ****** *** ********* ************ | ********* ******* ************ | ********* *** ****** *** ********* *** **** | *******, ********** *** *** ******* | *******, ********** *** *** ******* | ********* ******* ************ | ********* ******* ************* | ********* ******* ************* | ****** ** ********* *********-******* ************* | ****** ** ********* *********-******* ************* | ****** *** ********* ************ | ****** *** ********* ************ | ********* ******* ************* | ********* ******* ************ *** *********** ******* | ********** ******* *********** *** ****** ** ********* *** **** | ********** ******* *********** *** ****** ** ********* *** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|